Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Inclusion Criteria: * Male or female aged 18 or older * Diagnosed with histologically confirmed solid tumor located in the peripheral lung * Not candidate for curative surgery, is unfit for surgery, or does not wish to undergo curative surgery * May be candidate for, have failed, or does not wish to undergo radiation therapy * The tumor is ≤ 3 cm in size and clearly observable in computerized tomography (CT scan) * Able to sign an informed consent Exclusion Criteria: * Diagnostic of small cell lung cancer * Solid tumor located in central lung * Presence of concurrent non-solid malignancy * Abnormal blood results * Received chemotherapy/immunotherapy in the last 4 weeks * Tumor invades a major blood vessel * Porphyria or known hypersensitivity to Photofrin® or porphyrin-like compounds or to any of its excipients * Planned surgical procedure within the next 90 days * Coexisting ophthalmic disease likely to require slit-lamp examination within the next 90 days * Acute or chronic medical or psychological illnesses that prevent endoscopy procedures * Pregnant or intend to become pregnant, breastfeeding or intend to breastfeed during the study * Received PDT during the past 3 months * Severe impairment of your kidney or liver function * Participates or intends to participate in another drug study (other than observational studies) during the study